NCT02669628View on ClinicalTrials.gov

Antimullerian Hormone in Endometriomas

CompletedOBSERVATIONAL
Enrollment

34

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions
Endometriomas
Interventions
PROCEDURE

Surgical technique

Laparoscopic surgery

PROCEDURE

Alcohol sclerotherapy

US-guided sclerotherapy

Trial Locations (1)

08908

Hospital Universitario Bellvitge, L'Hospitalet de Llobregat

All Listed Sponsors
collaborator

Roche Diagnostic Ltd.

INDUSTRY

lead

Hospital Universitari de Bellvitge

OTHER

NCT02669628 - Antimullerian Hormone in Endometriomas | Biotech Hunter | Biotech Hunter